Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 4:57 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1921–1944 of 2,103 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Injectable saline Clear all

Conditions: Jaundice, Neonatal, Hyperbilirubinemia, Neonatal
Interventions: Phototherapy, Stannsoporfin, Placebo; Procedure · Drug
Lead sponsor: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company; Industry
Eligibility: 1 Hour to 72 Hours
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 18
States / cities: Colton, California • San Diego, California • San Francisco, California + 14 more

Conditions: Shivering, Nausea and Vomiting, Postoperative
Interventions: Dexmedetomidine, Placebo; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Photoaging
Interventions: Harvest PRP Separation System, Sterile Saline injection; Device · Other
Lead sponsor: Northwestern University; Other
Eligibility: 35 Years to 60 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Glenohumeral Osteoarthritis
Interventions: ZILRETTA, Placebo; Drug · Other
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 50 Years to 80 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 32
States / cities: Vestavia Hills, Alabama • Surprise, Arizona • Tucson, Arizona + 29 more

Conditions: Pain, Postoperative
Interventions: Liposomal Bupivacaine, 0.25% Bupivacaine with epinephrine, Saline; Drug
Lead sponsor: American Hip Institute; Other
Eligibility: 18 Years to 90 Years
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: Hinsdale, Illinois • Westmont, Illinois

Conditions: Anxiety Disorder Social, Anxiety
Interventions: botulinum toxin A, Placebo; Drug · Other
Lead sponsor: Daniel Lieberman; Other
Eligibility: 18 Years to 65 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Rotator Cuff Tears
Interventions: Tisseel Injectable Product, Stromal Vascular Fraction Cells; Drug · Biological
Lead sponsor: AdventHealth; Other
Eligibility: 30 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Osteoarthritis, Total Knee Replacement
Interventions: Ropivacaine injection, Saline Injection, Total Knee Arthroplasty; Drug · Procedure
Lead sponsor: OrthoCarolina Research Institute, Inc.; Other
Eligibility: 30 Years to 85 Years
Enrollment: 93 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Post-operative Pain
Interventions: Bupivacaine, Botulinum Toxins, Analgesics; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Asthma
Interventions: MCT, Clazakizumab, Broncho-Vaxom, Imatinib Mesylate, Cavosonstat, Placebo; Drug · Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 12 Years and older
Enrollment: 950 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 29
States / cities: Scottsdale, Arizona • Tucson, Arizona • Sacramento, California + 17 more

Conditions: Pain, Postoperative
Interventions: Bupivacaine, 0.9% Sodium Chloride; Drug
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Chattanooga, Tennessee

Conditions: Coronavirus (SARS-CoV)
Interventions: Aluminum hydroxide, Placebo, SARS-CoV; Drug · Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 40 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: Ends 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: HNSCC
Interventions: Motolimod, Nivolumab, Motolimod + Nivolumab; Drug · Biological · Combination Product
Lead sponsor: Presage Biosciences; Industry
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 5
States / cities: San Francisco, California • Chicago, Illinois • Winston-Salem, North Carolina + 1 more

Conditions: Equinus Contracture
Interventions: Botulinum toxin type A, sodium chloride; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Brain Metastases, Solid Tumors
Interventions: 2-(5-fluoro-pentyl)-2-methyl-malonic-acid ([18F]-ML-10), Stereotactic Radio-Surgery (SRS) therapy, Positron Emission Tomography; Drug · Radiation · Procedure
Lead sponsor: Aposense Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 4
States / cities: Boston, Massachusetts • New York, New York • Pittsburgh, Pennsylvania

Conditions: Peripheral Neuropathy Due to Chemotherapy
Interventions: IncobotulinumtoxinA (Xeomin®, Merz) (INA), Normal saline; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Acute Pain, Chronic Pain
Interventions: Dexamethasone, Placebo; Drug · Other
Lead sponsor: Duke University; Other
Eligibility: 55 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Non-small Cell Lung Cancer, Vomiting, Nausea, Emesis
Interventions: FOSAPREPITANT (Emend), Placebo; Drug
Lead sponsor: Ajeet Gajra; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Osteoporosis, Cerebral Palsy, Spina Bifida, Osteopenia, Osteogenesis Imperfecta
Interventions: pamidronate, saline; Drug · Other
Lead sponsor: University of New Mexico; Other
Eligibility: 4 Years to 18 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Pharmacokinetics, Safety, Tolerability
Interventions: 5-methoxy-N,N-dimethyltryptamine succinate salt, Placebo; Drug
Lead sponsor: Usona Institute; Other
Eligibility: 18 Years to 65 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Orthostatic Intolerance
Interventions: Ganirelix acetate, 17β-Oestradiol, Progesterone; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 34 Years · Female only
Enrollment: 109 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Pancreatitis, Acute
Interventions: Fluid administration; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 121 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Total Shoulder Arthroplasty
Interventions: Interscalene Block (ISB) - 0.375% Ropivacaine + additives, Interscalene Block (ISB) - 0.2% Ropivacaine + additives, Interscalene Block (ISB) - 0.1% Ropivacaine + additives, Interscalene Block (ISB) - Systemic Control; Procedure
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Rheumatoid Arthritis
Interventions: CDP6038, Tocilizumab (Actemra or RoActemra), Placebo sc, Placebo iv; Biological · Other
Lead sponsor: UCB Pharma; Industry
Eligibility: 18 Years and older
Enrollment: 221 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 74
States / cities: Mesa, Arizona • Paradise Valley, Arizona • Scottsdale, Arizona + 66 more

Search by objective public record fields.

Stannsoporfin With Light Therapy for Newborn Babies With Jaundice

Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering

Effect of Platelet Rich Plasma on Photoaged Skin

ZILRETTA in Subjects With Shoulder Osteoarthritis

Intraoperative Liposomal Bupivacaine vs. Bupivacaine for Total Hip Replacement Pain Management

A Study of the Efficacy of Botox in the Treatment of Social Anxiety Disorder

Stromal Vascular Fraction (SVF) Cells for Non-Operative Treatment of Small Rotator Cuff Tears

Adductor Canal Block

A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction

PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study

Para-cervical Block Prior to Laparoscopic Hysterectomy as an Adjuvant Treatment to Reduce Postoperative Pain.

SARS Coronavirus Vaccine (SARS-CoV)

Intratumoral Microdosing of Motolimod in HNSCC

The Effect of Botulinum Toxin A Injections on Ankle Dorsiflexion Following Internal Fixation of Tibial Pilon Fractures

Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

Botulinum Toxin A for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Dexamethasone and Pain Following Total Knee Arthroplasty

Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy

Prevention of Post Operative Bone Loss in Children

Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers

Sex Hormones and Orthostatic Tolerance

Lactated Ringer's Versus Normal Saline for Acute Pancreatitis

Analgesia After Total Shoulder Arthroplasty

Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy